Hudson Bay Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

$24.1 Billion
Q4 2024

A detailed history of Hudson Bay Capital Management LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 7,500 shares of ALNY stock, worth $1.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,500

Previous 18,262 58.93%

Holding current value

$1.78 Million

Previous $5.02 Million 64.88%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $2.5 Million - $3.23 Million	-10,762 Reduced 58.93%	7,500 $1.76 Million
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $2.74 Million - $3.37 Million	-11,738 Reduced 39.13%	18,262 $5.02 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $13.3 Million - $22.8 Million	-92,500 Reduced 75.51%	30,000 $7.29 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $5.86 Million - $7.93 Million	40,000 Added 48.48%	122,500 $18.3 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $5.54 Million - $7.19 Million	36,600 Added 79.74%	82,500 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $7.84 Million - $9.71 Million	45,900 New	45,900 $8.13 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $2.54 Million - $3.51 Million	-20,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $2.46 Million - $2.94 Million	20,000 New	20,000 $2.6 Million
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $5.59 Million - $8.04 Million	-60,000 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$74.51 - $124.23 $22,353 - $37,269	-300 Reduced 0.5%	60,000 $6.91 Million
Q3 2019 Nov 13, 2019	SELL	$70.9 - $87.82 $11 Million - $13.6 Million	-154,700 Reduced 71.95%	60,300 $4.85 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $10.9 Million - $15.3 Million	165,000 Added 330.0%	215,000 $15.6 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $363,800 - $467,250	-5,000 Reduced 9.09%	50,000 $4.67 Million
Q4 2018 Feb 13, 2019	SELL	$62.67 - $88.33 $313,350 - $441,650	-5,000 Reduced 8.33%	55,000 $4.01 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $2.63 Million - $3.68 Million	30,000 Added 100.0%	60,000 $5.25 Million
Q2 2018 Aug 13, 2018	BUY	$88.31 - $107.8 $2.65 Million - $3.23 Million	30,000 New	30,000 $2.96 Million

Others Institutions Holding ALNY

# of Institutions

667

Shares Held

112M

Call Options Held

839K

Put Options Held

771K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History